“avanir-pharmaceuitcals” Archives

Entry Author Date Location
How A Kidney Drug Almost Torpedoed Concert Pharma’s IPO 04/25/14 Boston
East Coast Biotech Roundup: Voyager, Concert, Retrophin, & More 02/14/14 Boston
Concert Pharma Heads to Nasdaq, Prices IPO at $14 Per Share 02/13/14 Boston
Biotechs Go Back to the Future by Re-Innovating Old Drugs 08/26/09 San Diego
Page 1 of 1